Sage Journals: Discover world-class research

Open access

Research article

First published 2017-10

TWIST mediates resistance to paclitaxel by regulating Akt and Bcl-2 expression in gastric cancer cells

Chae Hwa Kwon, Hye Ji Park, Yuri Choi [...]

Tumor Biology

Free access

Research article

First published 1999-4

C-erbB-2 in Serum of Patients Receiving Fractionated Paclitaxel Chemotherapy

D. Lüftner, S. Schnabel, K. Possinger

The International Journal of Biological Markers

Retricted access

Research article

First published 2000-07

Treatment of Anaplastic Thyroid Carcinoma with Paclitaxel: Phase 2 Trial Using Ninety-Six-hour Infusion

Kenneth B. Ain, Merrill J. Egorin, Philip A. DeSimone [...]

Thyroid®

Free access

Research article

First published 2004-8

Randomized Phase 2 Study of Radiotherapy Alone versus Radiotherapy with Paclitaxel in Non-Small Cell Lung Cancer

S Sarihan, U Kayisogullari, I Ercan [...]

Journal of International Medical Research

Retricted access

Research article

First published 2013-06

Overcoming Paclitaxel Resistance in Lung Cancer Cells Via Dual Inhibition of Stathmin and Bcl-2

Zheng-Xiang Han, Hong-Mei Wang, Guan Jiang [...]

Cancer Biotherapy and Radiopharmaceuticals

Open access

Research article

First published 2012-1

The Maintenance of Cisplatin- and Paclitaxel-Induced Mechanical and Cold Allodynia is Suppressed by Cannabinoid CB 2 Receptor Activation and Independent of CXCR4 Signaling in Models of Chemotherapy-Induced Peripheral Neuropathy

Liting Deng, Josée Guindon, V Kiran Vemuri [...]

Molecular Pain

Open access

Research article

First published 2021

Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline BRCA1 / 2 mutations and hormone receptor status from the phase-3 BROCADE3 trial

Jean-Pierre Ayoub, Hans Wildiers, Michael Friedlander [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2021

Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter,single-arm,open-label,phase 2 trial

Gunn Huh, Hee Seung Lee, Jin Ho Choi [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2017-9

Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model

Xiangjing Meng, Guangying Du, Liang Ye [...]

International Journal of Immunopathology and Pharmacology

Retricted access

Research article

First published 2009-06

Economic analysis of albumin-bound paclitaxel for the treatment of metastatic breast cancer

George Dranitsaris, Wayne Cottrell, Biljana Spirovski [...]

Journal of Oncology Pharmacy Practice

Search results